Wave Life Sciences Ltd. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Wave Life Sciences Ltd. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • Wave Life Sciences Ltd. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $247M, a 9.25% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $247M +$20.9M +9.25% Dec 31, 2023 10-K 2024-03-06
Q4 2022 $226M -$11.9M -5% Dec 31, 2022 10-K 2024-03-06
Q4 2021 $238M +$42.8M +21.9% Dec 31, 2021 10-K 2024-03-06
Q4 2020 $195M +$38.7M +24.7% Dec 31, 2020 10-K 2023-03-23
Q4 2019 $157M +$57.2M +57.6% Dec 31, 2019 10-K 2022-03-03
Q4 2018 $99.4M +$63.4M +176% Dec 31, 2018 10-K 2021-03-04
Q4 2017 $36.1M +$20.1M +125% Dec 31, 2017 10-K 2020-03-02
Q4 2016 $16M +$8.53M +114% Dec 31, 2016 10-K 2019-03-01
Q4 2015 $7.47M +$4.81M +181% Dec 31, 2015 10-K 2018-03-12
Q4 2014 $2.66M +$1.12M +73.3% Dec 31, 2014 10-K 2017-03-16
Q4 2013 $1.53M +$325K +26.9% Dec 31, 2013 10-K 2016-03-30
Q4 2012 $1.21M Dec 31, 2012 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.